These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17338883)

  • 1. [Atherosclerosis as a systemic disease].
    Lahoz C; Mostaza JM
    Rev Esp Cardiol; 2007 Feb; 60(2):184-95. PubMed ID: 17338883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis.
    Mogelvang R; Pedersen SH; Flyvbjerg A; Bjerre M; Iversen AZ; Galatius S; Frystyk J; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):515-20. PubMed ID: 22100028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
    Shankar A; Li J; Nieto FJ; Klein BE; Klein R
    Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.
    Horinaka S; Yabe A; Yagi H; Ishimura K; Hara H; Iemua T; Matsuoka H
    Angiology; 2009; 60(4):468-76. PubMed ID: 19015165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of biochemical risk factors and markers for the risk of atherosclerosis].
    Montagnana M; Lippi G; Salvagno GL; Franchini M; Targher G; Guidi GC
    Recenti Prog Med; 2008 Apr; 99(4):215-22. PubMed ID: 18595637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
    Blinc A; Poredos P
    Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
    Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
    Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
    J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Your heart attack risk: inflammation counts. A woman with normal cholesterol levels can still be at high risk for a heart attack. Should she have a test to find out?
    Harv Womens Health Watch; 2003 Feb; 10(6):1-3. PubMed ID: 12604436
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.